Abstract:Background: Sevoflurane has been shown to stimulate neurotoxicity and lead to cognitive impairment. Berberine is known for its role in regulating nervous system diseases, including cognitive dysfunction. This study aimed to investigate the effects of berberine on cognitive dysfunction induced by sevoflurane anesthesia and its potential mechanisms. Methods: In the in vivo study, neonatal mice were subjected to sevoflurane anesthesia to induce cognitive dysfunction. The cognitive function of the neonatal mice was evaluated using the Morris water maze test, open field test, and tail suspension test. Enzyme-linked immunosorbent assay (ELISA) was utilized to assess the levels of inflammatory factors. Immunohistochemistry (IHC) was conducted to detect ionized calcium-binding adaptor molecule 1 (IBA-1)-positive cells and cleaved caspase-3-positive cells in the hippocampus of the neonatal mice. Western blotting was used to measure the levels of cyclic adenosine monophosphate (cAMP) response element-binding protein 1 (CREB1) in hippocampal tissues and neurons. Hippocampal neurons were isolated from the hippocampus of neonatal mice. These neurons were treated with berberine or subjected to cell transfection. The cell counting kit-8 (CCK-8) assay and terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay were conducted to measure cell viability and apoptosis of hippocampal neurons in vitro. Results: Berberine significantly attenuated sevoflurane-induced cognitive impairment and inflammation in neonatal mice (p < 0.05 or p < 0.01). Additionally, berberine reduced sevoflurane-triggered neuronal apoptosis in the hippocampus of neonatal mice (p < 0.01). Sevoflurane markedly decreased CREB1 expression in the hippocampus of neonatal mice (p < 0.01), which was elevated by berberine treatment (p < 0.01). Mechanistically, sevoflurane significantly suppressed cell viability and promoted cell apoptosis of hippocampal neurons (p < 0.0001 or p < 0.01), which were mitigated by berberine (p < 0.05, p < 0.01, or p < 0.001). Furthermore, berberine significantly elevated CREB1 expression in sevoflurane-treated hippocampal neurons (p < 0.01). The beneficial effects of berberine on cell viability and apoptosis in sevoflurane-treated hippocampal neurons were blocked by CREB1 depletion (p < 0.001). Conclusion: Our results demonstrated that CREB1 was significantly decreased in the hippocampus of sevoflurane-treated neonatal mice in vivo and in sevoflurane-treated hippocampal neurons in vitro. This decrease was mitigated by berberine treatment. Moreover, berberine improved sevoflurane anesthesia-induced cognitive impairment in neonatal mice by attenuating neuronal inflammation and apoptosis in vivo. The inhibitory effects of berberine on sevoflurane-induced cell apoptosis were reversed by CREB1 downregulation. These findings indicate that berberine protects against sevoflurane anesthesia-induced cognitive impairment by reducing apoptosis of hippocampal neurons, partially through increasing CREB1 expression.

Berberine Alleviates Sevoflurane Anesthesia-Induced Cognitive Dysfunction in Neonatal Mice via Regulating CREB1

MicroRNA-325-3p prevents sevoflurane-induced learning and memory impairment by inhibiting Nupr1 and C/EBP/IGFBP5 signaling in rats

Role of Autophagy in Sevoflurane-Induced Neurotoxicity in Neonatal Rat Hippocampal Cells.

Mitophagy Impairment is Involved in Sevoflurane-Induced Cognitive Dysfunction in Aged Rats.

Effects Of Sevoflurane On Young Male Adult C57bl/6 Mice Spatial Cognition

Resveratrol ameliorates sevoflurane-induced cognitive impairment by activating the SIRT1/NF-κB pathway in neonatal mice

Inhibition of Adult Hippocampal Neurogenesis Plays a Role in Sevoflurane-Induced Cognitive Impairment in Aged Mice Through Brain-Derived Neurotrophic Factor/Tyrosine Receptor Kinase B and Neurotrophin-3/Tropomyosin Receptor Kinase C Pathways

Sevoflurane suppresses ALG13 transcription in a CREBBP-dependent manner to induce hippocampal damage and cognitive impairment

Microrna-181 Inhibitor Protects Against Sevoflurane-Induced Hippocampal Apoptosis And Memory Impairment

Sevoflurane Exposure in Postnatal Rats Induced Long-Term Cognitive Impairment Through Upregulating Caspase-3/Cleaved-poly (Adp-Ribose) Polymerase Pathway

Histone Deacetylase 9 Plays a Role in Sevoflurane‐induced Neuronal Differentiation Inhibition by Inactivating Camp‐response Element Binding Protein Transcription and Inhibiting the Expression of Neurotrophin‐3

Pre-administration of Curcumin Prevents Neonatal Sevoflurane Exposure-Induced Neurobehavioral Abnormalities in Mice.

The Role of Histone Acetylation in the Sevoflurane-induced Inhibition of Neurogenesis in the Hippocampi of Young Mice

Effects of Sevoflurane on Self-Renewal Capacity and Differentiation of Cultured Neural Stem Cells

The Effects of Metabotropic Glutamate Receptor 7 Allosteric Agonist N,N′-dibenzhydrylethane-1,2-diamine Dihydrochloride on Developmental Sevoflurane Neurotoxicity: Role of Extracellular Signal-Regulated Kinase 1 and 2 Mitogen-Activated Protein Kinase Signaling Pathway

Effect of histone demethylase KDM5B on long-term cognitive impairment in neonatal rats induced by sevoflurane

Knockdown of TNFAIP1 mitigates sevoflurane-induced cognitive dysfunction by activating CREB/Nrf2 pathway

AMPK‐SIRT1 pathway dysfunction contributes to neuron apoptosis and cognitive impairment induced by sevoflurane

Study on the effect of sevoflurane on the cognitive function of aged rats based on the activation of cortical microglia

Relationship between histone acetylation and NR2B-CREB-BDNF signaling pathway during sevoflurane-induced cognitive decline in aged mice

Inhibition of Protein Tyrosine Phosphatase 1B Protects Against Sevoflurane-Induced Neurotoxicity Mediated by ER Stress in Developing Brain